Literature DB >> 17958423

Homogeneous catalytic reduction of dioxygen using transfer hydrogenation catalysts.

Zachariah M Heiden1, Thomas B Rauchfuss.   

Abstract

Solutions of Cp*IrH(rac-TsDPEN) (TsDPEN = H2NCHPhCHPhN(SO2C6H4CH3)-) (1H(H)) with O2 generate Cp*Ir(TsDPEN-H) (1) and 1 equiv of H2O. Kinetic analysis indicates a third-order rate law (second order in [1H(H)] and first order in [O2]), resulting in an overall rate constant of 0.024 +/- 0.013 M(-2) s(-1). Isotopic labeling revealed that the rate of the reaction of 1H(H) + O2 was strongly affected by deuteration at the hydride position (k(HH2)/k(DH2) = 6.0 +/- 1.3) but insensitive to deuteration of the amine (k(HH2)/k(HD2) = 1.2 +/- 0.2); these values are more disparate than for conventional transfer hydrogenation (Casey, C. P.; Johnson, J. B. J. Org. Chem. 2003, 68, 1998-2001). The temperature dependence of the reaction rate indicated DeltaH = 82.2 kJ/mol, DeltaS = 13.2 J/mol K, and a reaction barrier of 85.0 kJ/mol. A CH2Cl2 solution under 0.30 atm of H2 and 0.13 atm of O2 converted to H2O in the presence of 1 and 10 mol % of H(OEt2)2BAr(F)4 (BAr(F)4- = B(C6H3-3,5-(CF3)2)4-). The formation of water from H2 was verified by 2H NMR for the reaction of D2 + O2. Solutions of 1 slowly catalyze the oxidation of amyl alcohol to pentanal; using 1,4-benzoquinone as a cocatalyst, the conversion was faster. Complex 1 also catalyzes the reaction of O2 with RNH2BH3 (R = H, t-Bu), resulting in the formation of water and H2. The deactivation of the catalyst 1 in its reactions with O2 was traced to degradation of the Cp* ligand to a fulvene derivative. This pathway is not observed in the presence of amine-boranes, which were shown to reduce fulvenes back to Cp*. This work suggests the potential of transfer hydrogenation catalysts in reactions involving O2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17958423     DOI: 10.1021/ja073774p

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  7 in total

1.  Catalytic reduction of dioxygen to water with a monomeric manganese complex at room temperature.

Authors:  Ryan L Shook; Sonja M Peterson; John Greaves; Curtis Moore; Arnold L Rheingold; A S Borovik
Journal:  J Am Chem Soc       Date:  2011-03-22       Impact factor: 15.419

2.  Transient Ru-methyl formate intermediates generated with bifunctional transfer hydrogenation catalysts.

Authors:  Richard H Perry; Kristen R Brownell; Konstantin Chingin; Thomas J Cahill; Robert M Waymouth; Richard N Zare
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

3.  Synthetic cascades are enabled by combining biocatalysts with artificial metalloenzymes.

Authors:  V Köhler; Y M Wilson; M Dürrenberger; D Ghislieri; E Churakova; T Quinto; L Knörr; D Häussinger; F Hollmann; N J Turner; T R Ward
Journal:  Nat Chem       Date:  2012-11-25       Impact factor: 24.427

4.  The potent oxidant anticancer activity of organoiridium catalysts.

Authors:  Zhe Liu; Isolda Romero-Canelón; Bushra Qamar; Jessica M Hearn; Abraha Habtemariam; Nicolas P E Barry; Ana M Pizarro; Guy J Clarkson; Peter J Sadler
Journal:  Angew Chem Int Ed Engl       Date:  2014-03-11       Impact factor: 15.336

5.  A generalized kinetic model for compartmentalization of organometallic catalysis.

Authors:  Brandon J Jolly; Nathalie H Co; Ashton R Davis; Paula L Diaconescu; Chong Liu
Journal:  Chem Sci       Date:  2022-01-05       Impact factor: 9.825

6.  Direct synthesis of hydrogen peroxide from hydrogen and oxygen by using a water-soluble iridium complex and flavin mononucleotide.

Authors:  Satoshi Shibata; Tomoyoshi Suenobu; Shunichi Fukuzumi
Journal:  Angew Chem Int Ed Engl       Date:  2013-10-25       Impact factor: 15.336

7.  Base-Promoted, Remote C-H Activation at a Cationic (η5-C5Me5)Ir(III) Center Involving Reversible C-C Bond Formation of Bound C5Me5.

Authors:  Juan J Moreno; María F Espada; Jesús Campos; Joaquín López-Serrano; Stuart A Macgregor; Ernesto Carmona
Journal:  J Am Chem Soc       Date:  2019-02-05       Impact factor: 15.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.